Natural killer cell responses to viral infection

Journal of Innate Immunity

Volumn 3, Issue 3, 2011, Pages 274-279

  Brandstadter, Joshua D ^a   Yang, Yiping ^a,b  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Innate immunity; Natural killer cells; Viral infection

Indexed keywords

ALPHA BETA INTERFERON RECEPTOR; ALPHA INTERFERON; BETA INTERFERON; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; HEMAGGLUTININ; HN PROTEIN; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; KILLER CELL ACTIVATING RECEPTOR ASSOCIATED PROTEIN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL3; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DS1; L SELECTIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NATURAL KILLER CELL RECEPTOR NKG2D; STAT1 PROTEIN; STAT2 PROTEIN; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; UNINDEXED DRUG;

CELL ACTIVATION; CELL MIGRATION; CELL PROLIFERATION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; CYTOTOXICITY; DENDRITIC CELL; DISEASE COURSE; EPSTEIN BARR VIRUS INFECTION; HERPES SIMPLEX VIRUS; HUMAN; INFECTION; INFLAMMATION; INNATE IMMUNITY; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; VIRUS INFECTION;

ANIMALS; CELL MOVEMENT; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; IMMUNITY, INNATE; IMMUNOTHERAPY; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; VIRUS DISEASES;

EID: 79955091252     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000324176     Document Type: Review

References (62)

1. Cerwenka A, Lanier LL: Natural killer cells, viruses and cancer. Nat Rev Immunol 2001; 1: 41-49. (Pubitemid 33741974)
2. Kiessling R, Klein E, Wigzell H: 'Natural' killer cells in the mouse. 1. Cytotoxic cells with specificity for mouse moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol 1975; 5: 112-117.
3. Herberman RB, Nunn ME, Lavrin DH: Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. 1. Distribution of reactivity and specificity. Int J Cancer 1975; 16: 216-229.
4. Karre K, Ljunggren HG, Piontek G, Kiessling R: Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 1986; 319: 675-678. (Pubitemid 16119452)
5. Orange JS: Human natural killer cell deficiencies and susceptibility to infection. Microbes Infect 2002; 4: 1545-1558. (Pubitemid 36050824)
6. Biron CA, Byron KS, Sullivan JL: Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med 1989; 320: 1731-1735. (Pubitemid 19163129)
7. Bukowski JF, Woda BA, Habu S, Okumura K, Welsh RM: Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo. J Immunol 1983; 131: 1531-1538. (Pubitemid 13048919)
8. Lee SH, Miyagi T, Biron CA: Keeping NK cells in highly regulated antiviral warfare. Trends Immunol 2007; 28: 252-259. (Pubitemid 46810349)
9. Stewart CA, Laugier-Anfossi F, Vely F, Saulquin X, Riedmuller J, Tisserant A, Gauthier L, Romagne F, Ferracci G, Arosa FA, Moretta A, Sun PD, Ugolini S, Vivier E: Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors. Proc Natl Acad Sci USA 2005; 102: 13224-13229. (Pubitemid 41325005)
10. Khakoo SI, Carrington M: KIR and disease: a model system or system of models? Immunol Rev 2006; 214: 186-201. (Pubitemid 44707911)
11. Lanier LL: Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol 2008; 9: 495-502. (Pubitemid 351560518)
12. Bryceson YT, Ljunggren HG, Long EO: Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors. Blood 2009; 114: 2657-2666.
13. Brown MG, Dokun AO, Heusel JW, Smith HR, Beckman DL, Blattenberger EA, Dubbelde CE, Stone LR, Scalzo AA, Yokoyama WM: Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 2001; 292: 934-937. (Pubitemid 32422491)
14. Smith HR, Heusel JW, Mehta IK, Kim S, Dorner BG, Naidenko OV, Iizuka K, Furukawa H, Beckman DL, Pingel JT, Scalzo AA, Fremont DH, Yokoyama WM: Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci USA 2002; 99: 8826-8831. (Pubitemid 34693643)
15. Arase H, Mocarski ES, Campbell AE, Hill AB, Lanier LL: Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 2002; 296: 1323-1326. (Pubitemid 34522789)
16. French AR, Yokoyama WM: Natural killer cells and viral infections. Curr Opin Immunol 2003; 15: 45-51. (Pubitemid 35454191)
17. Mandelboim O, Lieberman N, Lev M, Paul L, Arnon TI, Bushkin Y, Davis DM, Strominger JL, Yewdell JW, Porgador A: Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 2001; 409: 1055-1060. (Pubitemid 32204059)
18. Gazit R, Gruda R, Elboim M, Arnon TI, Katz G, Achdout H, Hanna J, Qimron U, Landau G, Greenbaum E, Zakay-Rones Z, Porgador A, Mandelboim O: Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat Immunol 2006; 7: 517-523.
19. Magri G, Muntasell A, Romo N, Saez-Borderias A, Pende D, Geraghty DE, Hengel H, Angulo A, Moretta A, Lopez-Botet M: NKp46 and DNAM-1 NK cell receptors drive the response to human cytomegalovirus infected myeloid dendritic cells overcoming viral immune evasion strategies. Blood 2011; 117: 848-856. DOI: blood-2010-08-301374.
20. Jamieson AM, Diefenbach A, McMahon CW, Xiong N, Carlyle JR, Raulet DH: The role of the NKg2d immunoreceptor in immune cell activation and natural killing. Immunity 2002; 17: 19-29. (Pubitemid 34874615)
21. Guma M, Angulo A, Lopez-Botet M: NK cell receptors involved in the response to human cytomegalovirus infection. Curr Top Microbiol Immunol 2006; 298: 207-223.
22. Andoniou CE, van Dommelen SL, Voigt V, Andrews DM, Brizard G, Asselin-Paturel C, Delale T, Stacey KJ, Trinchieri G, Degli-Esposti MA: Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity. Nat Immunol 2005; 6: 1011-1019. (Pubitemid 41486186)
23. Martinez J, Huang X, Yang Y: Direct TLR2 signaling is critical for NK cell activation and function in response to vaccinia viral infection. PLoS Pathog 2010; 6:e1000811.
24. Zhu J, Huang X, Yang Y: NKG2D is required for NK cell activation and function in response to E1-deleted adenovirus. J Immunol 2010; 185: 7480-7486.
25. Orange JS, Fassett MS, Koopman LA, Boyson JE, Strominger JL: Viral evasion of natural killer cells. Nat Immunol 2002; 3: 1006-1012. (Pubitemid 35363650)
26. Eissmann P, Evans JH, Mehrabi M, Rose EL, Nedvetzki S, Davis DM: Multiple mechanisms downstream of TLR-4 stimulation allow expression of NKG2D ligands to facilitate macrophage/NK cell crosstalk. J Immunol 2010; 184: 6901-6909.
27. Giurisato E, Cella M, Takai T, Kurosaki T, Feng Y, Longmore GD, Colonna M, Shaw AS: Phosphatidylinositol 3-kinase activation is required to form the NKG2D immunological synapse. Mol Cell Biol 2007; 27: 8583-8599.
28. Bryceson YT, March ME, Ljunggren HG, Long EO: Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood 2006; 107: 159-166. (Pubitemid 43053538)
29. Gilfillan S, Ho EL, Cella M, Yokoyama WM, Colonna M: NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation. Nat Immunol 2002; 3: 1150-1155. (Pubitemid 35469699)
30. Diefenbach A, Tomasello E, Lucas M, Jamieson AM, Hsia JK, Vivier E, Raulet DH: Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D. Nat Immunol 2002; 3: 1142-1149. (Pubitemid 35469698)
31. Sivori S, Falco M, Della Chiesa M, Carlomagno S, Vitale M, Moretta L, Moretta A: CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proc Natl Acad Sci USA 2004; 101: 10116-10121. (Pubitemid 38891204)
32. Schmidt KN, Leung B, Kwong M, Zarember KA, Satyal S, Navas TA, Wang F, Godowski PJ: APC-independent activation of NK cells by the Toll-like receptor 3 agonist doublestranded RNA. J Immunol 2004; 172: 138-143. (Pubitemid 38020465)
33. Hart OM, Athie-Morales V, O'Connor GM, Gardiner CM: TLR7/8-mediated activation of human NK cells results in accessory celldependent IFN-gamma production. J Immunol 2005; 175: 1636-1642. (Pubitemid 41023066)
34. Pesce I, Monaci E, Muzzi A, Tritto E, Tavarini S, Nuti S, De Gregorio E, Wack A: Intranasal administration of CpG induces a rapid and transient cytokine response followed by dendritic and natural killer cell activation and recruitment in the mouse lung. J Innate Immun 2010; 2: 144-159.
35. Mian MF, Lauzon NM, Andrews DW, Lichty BD, Ashkar AA: FimH can directly activate human and murine natural killer cells via TLR4. Mol Ther 2010; 18: 1379-1388.
36. Long EO: Negative signaling by inhibitory receptors: the NK cell paradigm. Immunol Rev 2008; 224: 70-84.
37. Moretta L, Ciccone E, Mingari MC, Biassoni R, Moretta A: Human natural killer cells: origin, clonality, specificity, and receptors. Adv Immunol 1994; 55: 341-380. (Pubitemid 24057057)
38. Wagtmann N, Rajagopalan S, Winter CC, Peruzzi M, Long EO: Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer. Immunity 1995; 3: 801-809. (Pubitemid 26092193)
39. Karlhofer FM, Ribaudo RK, Yokoyama WM: MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells. Nature 1992; 358: 66-70.
40. Stebbins CC, Watzl C, Billadeau DD, Leibson PJ, Burshtyn DN, Long EO: Vav1 dephosphorylation by the tyrosine phosphatase SHP-1 as a mechanism for inhibition of cellular cytotoxicity. Mol Cell Biol 2003; 23: 6291-6299. (Pubitemid 37013105)
41. Fernandez NC, Treiner E, Vance RE, Jamieson AM, Lemieux S, Raulet DH: A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood 2005; 105: 4416-4423. (Pubitemid 40720789)
42. Kim S, Poursine-Laurent J, Truscott SM, Lybarger L, Song YJ, Yang L, French AR, Sunwoo JB, Lemieux S, Hansen TH, Yokoyama WM: Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 2005; 436: 709-713. (Pubitemid 41117274)
43. Orr MT, Murphy WJ, Lanier LL: 'Unlicensed' natural killer cells dominate the response to cytomegalovirus infection. Nat Immunol 2010; 11: 321-327.
44. Dokun AO, Kim S, Smith HR, Kang HS, Chu DT, Yokoyama WM: Specific and nonspecific NK cell activation during virus infection. Nat Immunol 2001; 2: 951-956. (Pubitemid 32976168)
45. Nguyen KB, Salazar-Mather TP, Dalod MY, Van Deusen JB, Wei XQ, Liew FY, Caligiuri MA, Durbin JE, Biron CA: Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection. J Immunol 2002; 169: 4279-4287. (Pubitemid 35178200)
46. Garcia-Sastre A, Biron CA: Type 1 interferons and the virus-host relationship: a lesson in detente. Science 2006; 312: 879-882. (Pubitemid 43727313)
47. Orange JS, Biron CA: An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections. J Immunol 1996; 156: 1138-1142.
48. Gherardi MM, Ramirez JC, Esteban M: IL-12 and IL-18 act in synergy to clear vaccinia virus infection: involvement of innate and adaptive components of the immune system. J Gen Virol 2003; 84: 1961-1972. (Pubitemid 36927225)
49. Nguyen KB, Cousens LP, Doughty LA, Pien GC, Durbin JE, Biron CA: Interferon alpha/ beta-mediated inhibition and promotion of interferon gamma: STAT1 resolves a paradox. Nat Immunol 2000; 1: 70-76.
50. Gregoire C, Chasson L, Luci C, Tomasello E, Geissmann F, Vivier E, Walzer T: The trafficking of natural killer cells. Immunol Rev 2007; 220: 169-182. (Pubitemid 350045566)
51. Walzer T, Chiossone L, Chaix J, Calver A, Carozzo C, Garrigue-Antar L, Jacques Y, Baratin M, Tomasello E, Vivier E: Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor. Nat Immunol 2007; 8: 1337-1344. (Pubitemid 350131171)
52. Natuk RJ, Welsh RM: Accumulation and chemotaxis of natural killer/large granular lymphocytes at sites of virus replication. J Immunol 1987; 138: 877-883. (Pubitemid 17012407)
53. Salazar-Mather TP, Orange JS, Biron CA: Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1alpha (MIP- 1alpha)-dependent pathways. J Exp Med 1998; 187: 1-14. (Pubitemid 28044815)
54. Hokeness KL, Kuziel WA, Biron CA, Salazar- Mather TP: Monocyte chemoattractant protein-1 and CCR2 interactions are required for IFN-alpha/beta-induced inflammatory responses and antiviral defense in liver. J Immunol 2005; 174: 1549-1556.
55. Thapa M, Kuziel WA, Carr DJ: Susceptibility of CCR5-deficient mice to genital herpes simplex virus type 2 is linked to NK cell mobilization. J Virol 2007; 81: 3704-3713. (Pubitemid 46586867)
56. Chen JP, Lu HL, Lai SL, Campanella GS, Sung JM, Lu MY, Wu-Hsieh BA, Lin YL, Lane TE, Luster AD, Liao F: Dengue virus induces expression of CXC chemokine ligand 10/IFN-gamma-inducible protein 10, which competitively inhibits viral binding to cell surface heparan sulfate. J Immunol 2006; 177: 3185-3192. (Pubitemid 44304270)
57. Saudemont A, Garcon F, Yadi H, Roche-Molina M, Kim N, Segonds-Pichon A, Martin- Fontecha A, Okkenhaug K, Colucci F: p110gamma and p110delta isoforms of phosphoinositide 3-kinase differentially regulate natural killer cell migration in health and disease. Proc Natl Acad Sci USA 2009; 106: 5795-5800.
58. Prlic M, Gibbs J, Jameson SC: Characteristics of NK cell migration early after vaccinia infection. J Immunol 2005; 175: 2152-2157. (Pubitemid 41113820)
59. Lee SH, Biron CA: Here today - not gone tomorrow: roles for activating receptors in sustaining NK cells during viral infections. Eur J Immunol 2010; 40: 923-932.
60. Novelli F, Casanova JL: The role of IL-12, IL- 23 and IFN-gamma in immunity to viruses. Cytokine Growth Factor Rev 2004; 15: 367-377. (Pubitemid 39140700)
61. Tay CH, Welsh RM: Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells. J Virol 1997; 71: 267-275. (Pubitemid 26412288)
62. Colucci F, Caligiuri MA, Di Santo JP: What does it take to make a natural killer? Nat Rev Immunol 2003; 3: 413-425. (Pubitemid 37323201)